| Pemetrexed investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 145show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 445 trials (152 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 445 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 103 trials (30 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Squamous Non-Small Cell Carcinomasubtype 42 trials (14 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Mesotheliomacancer_family 34 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Mesothelioma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 34 trials (22 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 27 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Neoplasmcancer_family 20 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 16 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasmcancer_family 16 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Adenocarcinomasubtype 15 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasm 14 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Head and Neck Neoplasm 13 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Head and Neck Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Solid Neoplasm 12 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Solid Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pleural Malignant Mesotheliomasubtype 12 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Pleural Malignant Mesothelioma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Meningeal Carcinomatosis 11 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Meningeal Carcinomatosis | 11 | Observed | clinicaltrials | graph → |